CVE-2022-43557 affects BD BodyGuard™ infusion pumps, allowing physical access via the RS-232 serial port. This medium-severity vulnerability (CVSS 5.3) requires specialized equipment and knowledge, making exploitation complex but potentially allowing threat actors to configure or disable the pump. No patient data is at risk. There is no known active exploitation, publicly available exploit code, or significant community discussion surrounding this vulnerability.
| Vendor | Product | Version(s) | CPE |
|---|---|---|---|
Range not provided by sourceCPE matchmatch criteria | cpe:2.3:o:bd:bodyguard_999-603_firmware:-:*:*:*:*:*:*:* | ||
Range not provided by sourceCPE matchmatch criteria | cpe:2.3:o:bd:bodyguard_duo_999-903_firmware:-:*:*:*:*:*:*:* | ||
Range not provided by sourceCPE matchmatch criteria | cpe:2.3:o:bd:bodyguard_epidural_999-683_firmware:-:*:*:*:*:*:*:* | ||
Range not provided by sourceCPE matchmatch criteria | cpe:2.3:o:bd:bodyguard_pain_manager_999-803_firmware:-:*:*:*:*:*:*:* | ||
Range not provided by sourceCPE matchmatch criteria | cpe:2.3:o:bd:bodyguard_t_999-103_firmware:-:*:*:*:*:*:*:* |
CVSS version used by this source: 3.1
CVSS:3.1/AV:P/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:H
The average CVE in this peer group has 0.0 Twitter, 0.0 Reddit, 0.1 Bluesky, 0.0 Mastodon, and 0.1 GitHub mentions.
No media coverage found for this CVE.
The average CVE in this peer group has 0.2 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.
Remediation records are not available for this CVE.